AI assistant
PFIZER INC — Director's Dealing 2021
Mar 1, 2021
29831_dirs_2021-03-01_d75556bd-931b-4895-95e4-c23ab5330a20.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2021-02-25
Reporting Person: Dolsten Mikael (President R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-25 | Common Stock | F | 28271.0000 | $33.8200 | Disposed | 156568.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-25 | Stock Appreciation Rights | $33.8200 | A | 210697.0000 | Acquired | 2026-02-25 | Common Stock (210697.0000) | Direct |
| 2021-02-25 | Stock Appreciation Rights | $33.8200 | A | 182050.0000 | Acquired | 2028-02-25 | Common Stock (182050.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1758.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).
F2: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F3: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.